Delivery Order SPE2DB20D1050-SPE2DB25FH65F
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,955,471 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $1,265.40 contract has a period of performance through March 14, 2024 and does not have a set-aside designation. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The contract, which has a potential value of $3,771.04, is for the supply of 4,563,472,692 BOOSTRIX TDAP vaccine syringes (0.5ml). The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is a subsidiary of Amerisourcebergen Corporation, a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,044.78 firm fixed-price contract is for the delivery of 4,568,115,914 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has an ultimate completion date of May 5, 2025 and was awarded on May 2, 2025. This delivery order is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,092,038 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a firm fixed price of $16,764.30 and a completion date of May 1, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,150,456 units of the BOOSTRIX TDAP vaccine syringe (0.5mL). The contract has a ceiling value of $3,546.48 and is a firm fixed-price, non-set-aside contract with a period of performance through May 7, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a ceiling value of $9,572.76 and an ultimate completion date of November 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.40, is for the delivery of 4,568,032,429 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 0.5 ml BOOSTRIX TDAP vaccine syringes, with a potential value of $1,031.12 and a completion date of March 7, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger indefinite delivery...
This is a $4,085.47 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide BOOSTRIX TDAP vaccine syringes. The contract has an ultimate completion date of July 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which enables the DLA to efficiently procure a...
This is a $7,592.40 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4565256886 BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has an ultimate completion date of July 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive...